Silq Technologies Selected to Exhibit ClearTract™ Indwelling Foley Catheter at Vizient Innovative Technology Exchange
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies, a leader in advanced biomaterial science, has been selected to exhibit its novel ClearTract™ indwelling Foley catheter at the upcoming Vizient Innovative Technology Exchange. The ClearTract™ catheter is treated with a proprietary formulation which permanently transforms its surface and is designed to minimize catheter-related complications. Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine, Texas.
The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their product or service to supply chain and clinical leaders from Vizient’s member hospitals and subject matter experts who serve on their supply councils. Each product or service will showcase how it improves clinical outcomes, enhances safety, or drives incremental improvements to health care delivery or business models.
Silq Technologies is the first company in the world to commercialize zwitterion technology in silicone-based medical devices. ClearTract™, its first product, has been FDA cleared for sale for urethral, suprapubic and nephrostomy applications. The surface treatment is intended to minimize biofilm formation, urinary tract infection, encrustation and blockage, and may significantly reduce healthcare costs associated with the management and treatment of these complications.
Silq’s novel zwitterionic surface treatment can be applied to plastic and elastomeric materials widely used in implantable medical devices. For the past 20 years, zwitterion chemistry has been recognized as one of the most powerful technologies to resist the deposition of organic materials on synthetic surfaces, thereby minimizing bacterial growth with the added benefit of enhanced lubricity.
“We are honored and excited to be chosen to bring ClearTract™ to the Vizient Innovative Technology Exchange,” said D. Verne Sharma, President and CEO, Silq Technologies. “Developing innovative solutions that elevate the performance of medical devices is at the heart of our mission. We look forward to participating in this important forum and sharing the major advance in bladder management technology that our product represent.”
“Suppliers apply to attend the Exchange hoping their product will be awarded an Innovative Technology contract, which signals health care providers of their product’s unique qualities,” “said Kelly Flaharty, senior director of contract services, Vizient. “The selection process for suppliers who exhibit at the Exchange is rigorous, and this technology has earned its coveted invitation to the event.”
The annual Innovative Technology Exchange is part of Vizient’s Innovative Technology Program that includes product review of supplier-submitted technologies by member-led councils and task forces. Since 2003, Vizient has reviewed over 1,600 product submissions as part of its Innovative Technology Program.
About Silq Technologies Corporation
Silq Technologies is a leader in advanced biomaterials. The company’s patented technology and scalable manufacturing platform deliver a unique surface treatment that is designed to resist the adhesion of organic material, thereby improving the effectiveness, efficiency, and safety of a broad range of commercial products. The technology can be used in medical devices, medical implants, microfluidics, lithium-ion batteries, water treatment facilities, and much more. For additional information, visit https://www.silq.tech/.
STAKE Investor Relations